glp 1 and anesthesia risk GLP-1 drugs aspiration GLP-1 agonists and anesthesia risk:

Translational challenges for these agents are also discussed, particularly the need to understand how the timing of treatment may influence outcomes

TRT and GLP-1 are the two drugs that would get an athlete banned

An understanding of their effects on BP may help provide an explanation for the ability of GLP-1a to influence cardiovascular (CV) events in ongoing event-driven CV trials.

That rule is a heuristic, not a biological law

First non-insulin drug for pediatric use approved in nearly 20 years.

GLP-1 receptor agonists offer metabolic benefits but carry documented side effects, contraindications, and cost barriers